Skeletal aspects of Gaucher disease: a review
Authors:
- R J WenstrupRWR J Wenstrup
- M Roca-EspiauMRM Roca-Espiau
- N J WeinrebNWN J Weinreb
- B BembiBBB Bembi
- 24 May 2002
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 75 (suppl_1) , A2-A12
Abstract
In Gaucher disease, a genetic deficiency in the activity of the lysosomal enzyme beta-glucocerebrosidase (acid beta-glucosidase) causes monocytes and macrophages to store excessive amounts of glucocerebroside in lysosomes. The resulting distended cells are called Gaucher cells, and the pathology associated with this condition stems from the accumulation of Gaucher cells in organ systems. The skeletal manifestations are probably the most disabling aspect of the disease. Patients commonly experience bone pain, some suffer bone crises, and up to 20% have impaired mobility. Radiological findings include Erlenmeyer flask deformity, osteopenia, osteosclerosis, osteonecrosis, fractures and bone marrow infiltration. Findings from the Gaucher Registry show that nearly all patients with Gaucher disease have radiological evidence of skeletal involvement, and the majority have a history of serious skeletal complications. Skeletal involvement follows three basic processes: focal disease (irreversible lesions such as osteonecrosis and osteosclerosis), local disease (reversible abnormalities adjacent to heavily involved marrow such as cortical thinning and long bone deformity) and generalized osteopenia. Infarctions are involved in some of the skeletal manifestations, but the mechanisms causing high rates of bone turnover and failure of remodelling are not known. The availability of a beta-glucocerebrosidase-deficient mouse model of Gaucher disease with long-term survival should help elucidate the skeletal pathology in Gaucher disease and may ultimately lead to improved management of skeletal complications.Keywords
This publication has 39 references indexed in Scilit:
- Novel strategies for the treatment of osteoarthritisExpert Opinion on Investigational Drugs, 2000
- Analysis and Classification of 304 Mutant Alleles in Patients with Type 1 and Type 3 Gaucher DiseaseThe American Journal of Human Genetics, 2000
- Type 2 Gaucher Disease: An Expanding PhenotypeMolecular Genetics and Metabolism, 1999
- Novel Serum Markers of Bone Resorption: Clinical Assessment and Comparison with Established Urinary IndicesJournal of Bone and Mineral Research, 1999
- CHANGES IN CYTOKINE PRODUCTION OF BREAST CANCER PATIENTS TREATED WITH INTERFERONSCytokine, 1998
- Short-Term Effects of Pamidronate in Patients with Gaucher's Disease and Severe Skeletal InvolvementNew England Journal of Medicine, 1997
- Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10QJM: An International Journal of Medicine, 1997
- Enzyme replacement treatment in type 1 and type 3 Gaucher's diseaseThe Lancet, 1994
- Skeletal Scintigraphy of Pseudo-Osteomyelitis in Gaucher??s DiseaseClinical Nuclear Medicine, 1992
- Skeletal Complications of Gaucher DiseaseMedicine, 1985